Introduction:
AtomVie Global Radiopharma Inc. (AtomVie) has started the construction of a new radiopharmaceutical state-of-the-art facility in Hamilton, Ontario, Canada.
Features:
AtomVie's new 64,000 square foot facility, which is currently situated on the grounds of McMaster University, will be used exclusively for the high volume clinical and commercial GMP manufacturing and global distribution of radiotherapeutics, a novel, and fast-growing class of medications for the treatment of cancer patients.
More than 10 multinational radiopharmaceutical GMP manufacturing programmes are housed at AtomVie's world-class Contract Development and Manufacturing Organization (CDMO) facility.
Its clinical and commercial operations will be able to expand in order to satisfy the demands of the rapidly growing radiopharmaceutical market due to the new facility, which is anticipated to be operational in 2024.
Cleanrooms and labs to support over 18 production lines, as well as space for specialized, high-volume commercial manufacturing, are distinguishing features of the new facility.
The building is ideally situated close to the USA border, John C. Munro Hamilton International Airport, and Toronto Pearson International Airport.
With the ability to serve patients locally and globally, AtomVie is in a good situation to maintain and expand its position as a market leader in radiopharmaceutical GMP manufacturing.
Specifications:
| Name | AtomVie Global Radiopharma Inc |
| Type | New Construction |
| Year | 2024 |
